CANAAN X L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CANAAN X L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CANAAN X L.P.. CANAAN X L.P. is 10% Owner in Protagonist Therapeutics, Inc ($PTGX) and Director in Protagonist Therapeutics, Inc ($PTGX) and Director in Iterum Therapeutics plc ($ITRM) and 10% Owner in NextCure, Inc. ($NXTC) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA).
Latest Insider Trading Transactions of CANAAN X L.P.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDYA, ITRM, NXTC, PTGX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 602,549 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,658,164 | 0 | 0 | |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Buy | P | 10.00 | 400,000 | 4,000,000 | 2,660,713 | 2.3 M to 2.7 M (+17.69 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 602,549 | 0 | 2,260,713 | 1.7 M to 2.3 M (+36.34 %) |
May 28 2019 | IDYA | IDEAYA Biosciences ... | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 1,658,164 | 0 | 1,658,164 | 0 to 1.7 M |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,296,605 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,861,455 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 5,970,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,582,000 | 0 | 0 | |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | P | 15.00 | 50,000 | 750,000 | 2,254,442 | 2.2 M to 2.3 M (+2.27 %) |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 285,867 | 0 | 2,204,442 | 1.9 M to 2.2 M (+14.90 %) |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 729,599 | 0 | 1,918,575 | 1.2 M to 1.9 M (+61.36 %) |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 743,110 | 0 | 1,188,976 | 445.9 K to 1.2 M (+166.67 %) |
May 13 2019 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% Owner | Buy | C | 0.00 | 445,866 | 0 | 445,866 | 0 to 445.9 K |
May 30 2018 | ITRM | Iterum Therapeutic ... | CANAAN X L.P. | Director | Option Exercise | C | 0.00 | 229,660 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | CANAAN X L.P. | Director | Option Exercise | C | 0.00 | 275,446 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | CANAAN X L.P. | Director | Option Exercise | C | 0.00 | 721,408 | 0 | 0 | |
May 30 2018 | ITRM | Iterum Therapeutic ... | CANAAN X L.P. | Director | Buy | P | 13.00 | 506,656 | 6,586,528 | 1,733,170 | 1.2 M to 1.7 M (+41.31 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | CANAAN X L.P. | Director | Buy | C | 0.00 | 229,660 | 0 | 1,226,514 | 996.9 K to 1.2 M (+23.04 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | CANAAN X L.P. | Director | Buy | C | 0.00 | 275,446 | 0 | 996,854 | 721.4 K to 996.9 K (+38.18 %) |
May 30 2018 | ITRM | Iterum Therapeutic ... | CANAAN X L.P. | Director | Buy | C | 0.00 | 721,408 | 0 | 721,408 | 0 to 721.4 K |
May 21 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 6.09 | 38,968 | 237,358 | 2,116,552 | 2.2 M to 2.1 M (-1.81 %) |
May 16 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 6.46 | 29,441 | 190,071 | 2,155,520 | 2.2 M to 2.2 M (-1.35 %) |
May 16 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 6.48 | 57,715 | 374,080 | 2,184,961 | 2.2 M to 2.2 M (-2.57 %) |
May 16 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 6.37 | 77,591 | 494,224 | 2,242,676 | 2.3 M to 2.2 M (-3.34 %) |
Mar 26 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.71 | 59,950 | 1,241,325 | 2,320,267 | 2.4 M to 2.3 M (-2.52 %) |
Mar 22 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.62 | 4,759 | 98,133 | 2,380,217 | 2.4 M to 2.4 M (-0.20 %) |
Mar 22 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.61 | 17,699 | 364,727 | 2,384,976 | 2.4 M to 2.4 M (-0.74 %) |
Mar 22 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.61 | 17,060 | 351,538 | 2,402,675 | 2.4 M to 2.4 M (-0.71 %) |
Mar 19 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.57 | 13,439 | 276,446 | 2,419,735 | 2.4 M to 2.4 M (-0.55 %) |
Mar 19 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.51 | 6,926 | 142,063 | 2,433,174 | 2.4 M to 2.4 M (-0.28 %) |
Mar 15 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.64 | 11,751 | 242,521 | 2,440,100 | 2.5 M to 2.4 M (-0.48 %) |
Mar 15 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.77 | 200 | 4,154 | 2,451,851 | 2.5 M to 2.5 M (-0.01 %) |
Mar 15 2018 | PTGX | Protagonist Therap ... | CANAAN X L.P. | 10% Owner | Sell | S | 20.84 | 1,204 | 25,094 | 2,452,051 | 2.5 M to 2.5 M (-0.05 %) |
Aug 16 2016 | PTGX | Protagonist Therap ... | CANAAN X L.P. | Director | Option Exercise | C | 0.00 | 27,113,877 | 0 | 0 | |
Aug 16 2016 | PTGX | Protagonist Therap ... | CANAAN X L.P. | Director | Buy | P | 12.00 | 583,333 | 6,999,996 | 2,453,255 | 1.9 M to 2.5 M (+31.20 %) |
Aug 16 2016 | PTGX | Protagonist Therap ... | CANAAN X L.P. | Director | Buy | C | 0.00 | 1,869,922 | 0 | 1,869,922 | 0 to 1.9 M |
Page: 1